Form 4: BioLife Solutions Director Timothy Moore Acquires Shares

Director Timothy L. Moore reports acquisition of 6,876 shares of BioLife Solutions Inc. common stock on March 18, 2025.

Summary

• On March 18, 2025, Timothy L. Moore, a director of BioLife Solutions Inc., acquired 6,876 shares of common stock.
• Following the transaction, Moore directly owns 36,773 shares of BioLife Solutions Inc.
• The restricted stock was granted under the BioLife Solutions 2023 Performance Incentive Plan.
• The shares fully vest on the first anniversary of the measurement date of January 2, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition by a director. The acquisition itself can be seen as slightly positive, but the filing is purely informational.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

BioLife Solutions, BLFS, Form 4, Insider Trading, Timothy Moore, Stock Acquisition, Director, Beneficial Ownership, Restricted Stock, 2023 Performance Incentive Plan